{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:40:39Z","timestamp":1792820439997,"version":"4.5.0"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AF056850"],"award-info":[{"award-number":["AF056850"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG066512"],"award-info":[{"award-number":["AG066512"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG056850"],"award-info":[{"award-number":["AG056850"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG060882"],"award-info":[{"award-number":["AG060882"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Amyloid plaques contain many proteins in addition to beta amyloid (A\u03b2). Previous studies examining plaque-associated proteins have shown these additional proteins are important; they provide insight into the factors that drive amyloid plaque development and are potential biomarkers or therapeutic targets for Alzheimer\u2019s disease (AD). The aim of this study was to comprehensively identify proteins that are enriched in amyloid plaques using unbiased proteomics in two subtypes of early onset AD: sporadic early onset AD (EOAD) and Down Syndrome (DS) with AD. We focused our study on early onset AD as the drivers of the more aggressive pathology development in these cases is unknown and it is unclear whether amyloid-plaque enriched proteins differ between subtypes of early onset AD. Amyloid plaques and neighbouring non-plaque tissue were microdissected from human brain sections using laser capture microdissection and label-free LC\u2013MS was used to quantify the proteins present. 48 proteins were consistently enriched in amyloid plaques in EOAD and DS. Many of these proteins were more significantly enriched in amyloid plaques than A\u03b2. The most enriched proteins in amyloid plaques in both EOAD and DS were: COL25A1, SMOC1, MDK, NTN1, OLFML3 and HTRA1. Endosomal\/lysosomal proteins were particularly highly enriched in amyloid plaques. Fluorescent immunohistochemistry was used to validate the enrichment of four proteins in amyloid plaques (moesin, ezrin, ARL8B and SMOC1) and to compare the amount of total A\u03b2, A\u03b240, A\u03b242, phosphorylated A\u03b2, pyroglutamate A\u03b2 species and oligomeric species in EOAD and DS. These studies showed that phosphorylated A\u03b2, pyroglutamate A\u03b2 species and SMOC1 were significantly higher in DS plaques, while oligomers were significantly higher in EOAD. Overall, we observed that amyloid plaques in EOAD and DS largely contained the same proteins, however the amount of enrichment of some proteins was different in EOAD and DS. Our study highlights the significant enrichment of many proteins in amyloid plaques, many of which may be potential therapeutic targets and\/or biomarkers for AD.<\/jats:p>","DOI":"10.1186\/s40478-022-01356-1","type":"journal-article","created":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T08:07:10Z","timestamp":1649837230000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":148,"title":["The amyloid plaque proteome in early onset Alzheimer\u2019s disease and Down syndrome"],"prefix":"10.1186","volume":"10","author":[{"given":"Eleanor","family":"Drummond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Kavanagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Pires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Marta-Ariza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny","family":"Kanshin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arline","family":"Faustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Berdah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrix","family":"Ueberheide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3379-8966","authenticated-orcid":false,"given":"Thomas","family":"Wisniewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,13]]},"reference":[{"issue":"2","key":"1356_CR1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0304-3940(92)90444-C","volume":"135","author":"T Wisniewski","year":"1992","unstructured":"Wisniewski T, Frangione B (1992) Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 135(2):235\u2013238","journal-title":"Neurosci Lett"},{"issue":"13","key":"1356_CR2","doi-asserted-by":"publisher","first-page":"6084","DOI":"10.1016\/S0021-9258(17)38495-8","volume":"261","author":"I Grundke-Iqbal","year":"1986","unstructured":"Grundke-Iqbal I et al (1986) Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 261(13):6084\u20139","journal-title":"J Biol Chem"},{"issue":"17","key":"1356_CR3","doi-asserted-by":"publisher","first-page":"7552","DOI":"10.1073\/pnas.88.17.7552","volume":"88","author":"P Cras","year":"1991","unstructured":"Cras P et al (1991) Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. Proc Natl Acad Sci U S A 88(17):7552\u20137556","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1356_CR4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s40478-019-0848-6","volume":"7","author":"G Pires","year":"2019","unstructured":"Pires G et al (2019) Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer\u2019s disease and not in other tauopathies. Acta Neuropathol Commun 7(1):195","journal-title":"Acta Neuropathol Commun"},{"key":"1356_CR5","doi-asserted-by":"publisher","first-page":"104784","DOI":"10.1016\/j.nbd.2020.104784","volume":"138","author":"T Wisniewski","year":"2020","unstructured":"Wisniewski T, Drummond E (2020) APOE-amyloid interaction: therapeutic targets. Neurobiol Dis 138:104784","journal-title":"Neurobiol Dis"},{"issue":"1","key":"1356_CR6","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s40478-020-01075-5","volume":"8","author":"T Hashimoto","year":"2020","unstructured":"Hashimoto T et al (2020) Collagenous Alzheimer amyloid plaque component impacts on the compaction of amyloid-beta plaques. Acta Neuropathol Commun 8(1):212","journal-title":"Acta Neuropathol Commun"},{"issue":"16","key":"1356_CR7","doi-asserted-by":"publisher","first-page":"10843","DOI":"10.1073\/pnas.162228299","volume":"99","author":"RB DeMattos","year":"2002","unstructured":"DeMattos RB et al (2002) Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 99(16):10843\u201310848","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"1356_CR8","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H et al (2017) A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169(7):1276\u20131290","journal-title":"Cell"},{"key":"1356_CR9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fnagi.2018.00114","volume":"10","author":"BG Perez-Nievas","year":"2018","unstructured":"Perez-Nievas BG, Serrano-Pozo A (2018) Deciphering the astrocyte reaction in Alzheimer\u2019s disease. Front Aging Neurosci 10:114","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"1356_CR10","doi-asserted-by":"publisher","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A et al (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1(1):a006189","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"6","key":"1356_CR11","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00401-017-1691-0","volume":"133","author":"E Drummond","year":"2017","unstructured":"Drummond E et al (2017) Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer\u2019s disease. Acta Neuropathol 133(6):933\u2013954","journal-title":"Acta Neuropathol"},{"issue":"9","key":"1356_CR12","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1093\/brain\/awaa223","volume":"143","author":"E Drummond","year":"2020","unstructured":"Drummond E et al (2020) Phosphorylated tau interactome in the human Alzheimer\u2019s disease brain. Brain 143(9):2803\u20132817","journal-title":"Brain"},{"key":"1356_CR13","doi-asserted-by":"publisher","first-page":"15456","DOI":"10.1038\/srep15456","volume":"5","author":"ES Drummond","year":"2015","unstructured":"Drummond ES et al (2015) Proteomic analysis of neurons microdissected from formalin-fixed, paraffin-embedded Alzheimer\u2019s disease brain tissue. Sci Rep 5:15456","journal-title":"Sci Rep"},{"issue":"Pt 4","key":"1356_CR14","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1093\/brain\/awv006","volume":"138","author":"ML Cohen","year":"2015","unstructured":"Cohen ML et al (2015) Rapidly progressive Alzheimer\u2019s disease features distinct structures of amyloid-beta. Brain 138(Pt 4):1009\u20131022","journal-title":"Brain"},{"issue":"9","key":"1356_CR15","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S1474-4422(11)70156-9","volume":"10","author":"ME Murray","year":"2011","unstructured":"Murray ME et al (2011) Neuropathologically defined subtypes of Alzheimer\u2019s disease with distinct clinical characteristics: a retrospective study. Lancet Neurol 10(9):785\u2013796","journal-title":"Lancet Neurol"},{"issue":"1","key":"1356_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13195-020-00712-4","volume":"12","author":"S Emrani","year":"2020","unstructured":"Emrani S et al (2020) APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer\u2019s disease: a systematic review. Alzheimers Res Ther 12(1):141","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"1356_CR17","doi-asserted-by":"publisher","first-page":"eabb5398","DOI":"10.1126\/sciadv.abb5398","volume":"7","author":"RA Neff","year":"2021","unstructured":"Neff RA et al (2021) Molecular subtyping of Alzheimer\u2019s disease using RNA sequencing data reveals novel mechanisms and targets. Sci Adv 7(2):eabb5398","journal-title":"Sci Adv"},{"issue":"5","key":"1356_CR18","doi-asserted-by":"publisher","first-page":"e512","DOI":"10.1212\/NXG.0000000000000512","volume":"6","author":"C Reitz","year":"2020","unstructured":"Reitz C, Rogaeva E, Beecham GW (2020) Late-onset vs nonmendelian early-onset Alzheimer disease: a distinction without a difference? Neurol Genet 6(5):e512","journal-title":"Neurol Genet"},{"issue":"6","key":"1356_CR19","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S1474-4422(16)00063-6","volume":"15","author":"C Ballard","year":"2016","unstructured":"Ballard C et al (2016) Dementia in Down\u2019s syndrome. Lancet Neurol 15(6):622\u2013636","journal-title":"Lancet Neurol"},{"issue":"1","key":"1356_CR20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nm0196-93","volume":"2","author":"JK Teller","year":"1996","unstructured":"Teller JK et al (1996) Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down\u2019s syndrome. Nat Med 2(1):93\u201395","journal-title":"Nat Med"},{"issue":"4","key":"1356_CR21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.5858\/2001-125-0489-IAAPDO","volume":"125","author":"KA Gyure","year":"2001","unstructured":"Gyure KA et al (2001) Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome. Arch Pathol Lab Med 125(4):489\u2013492","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"1356_CR22","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3109\/13506120208995241","volume":"9","author":"C Mori","year":"2002","unstructured":"Mori C et al (2002) Intraneuronal Abeta42 accumulation in Down syndrome brain. Amyloid 9(2):88\u2013102","journal-title":"Amyloid"},{"issue":"1","key":"1356_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1006\/nbdi.1996.0003","volume":"3","author":"CA Lemere","year":"1996","unstructured":"Lemere CA et al (1996) Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiol Dis 3(1):16\u201332","journal-title":"Neurobiol Dis"},{"issue":"3","key":"1356_CR24","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ana.410170310","volume":"17","author":"KE Wisniewski","year":"1985","unstructured":"Wisniewski KE, Wisniewski HM, Wen GY (1985) Occurrence of neuropathological changes and dementia of Alzheimer\u2019s disease in Down\u2019s syndrome. Ann Neurol 17(3):278\u2013282","journal-title":"Ann Neurol"},{"issue":"1","key":"1356_CR25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40478-018-0559-4","volume":"6","author":"YS Davidson","year":"2018","unstructured":"Davidson YS et al (2018) The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer\u2019s disease in individuals with Down syndrome. Acta Neuropathol Commun 6(1):56","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"1356_CR26","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jalz.2018.01.002","volume":"14","author":"AD Cohen","year":"2018","unstructured":"Cohen AD et al (2018) Early striatal amyloid deposition distinguishes Down syndrome and autosomal dominant Alzheimer\u2019s disease from late-onset amyloid deposition. Alzheimers Dement 14(6):743\u2013750","journal-title":"Alzheimers Dement"},{"issue":"4","key":"1356_CR27","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00401-018-1866-3","volume":"136","author":"DMA Mann","year":"2018","unstructured":"Mann DMA et al (2018) Patterns and severity of vascular amyloid in Alzheimer\u2019s disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer\u2019s disease. Acta Neuropathol 136(4):569\u2013587","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1356_CR28","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s40478-020-00959-w","volume":"8","author":"S Kumar","year":"2020","unstructured":"Kumar S, Lemere CA, Walter J (2020) Phosphorylated Abeta peptides in human Down syndrome brain and different Alzheimer\u2019s-like mouse models. Acta Neuropathol Commun 8(1):118","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"1356_CR29","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ajpath.2013.05.005","volume":"183","author":"JL Frost","year":"2013","unstructured":"Frost JL et al (2013) Pyroglutamate-3 amyloid-beta deposition in the brains of humans, non-human primates, canines, and Alzheimer disease-like transgenic mouse models. Am J Pathol 183(2):369\u2013381","journal-title":"Am J Pathol"},{"issue":"2","key":"1356_CR30","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/0896-6273(95)90301-1","volume":"14","author":"TC Saido","year":"1995","unstructured":"Saido TC et al (1995) Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques. Neuron 14(2):457\u2013466","journal-title":"Neuron"},{"issue":"6","key":"1356_CR31","first-page":"1823","volume":"149","author":"T Iwatsubo","year":"1996","unstructured":"Iwatsubo T et al (1996) Full-length amyloid-beta (1\u201342(43)) and amino-terminally modified and truncated amyloid-beta 42(43) deposit in diffuse plaques. Am J Pathol 149(6):1823\u20131830","journal-title":"Am J Pathol"},{"issue":"1","key":"1356_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ et al (2012) National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol 123(1):1\u201311","journal-title":"Acta Neuropathol"},{"issue":"2","key":"1356_CR33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3233\/JAD-2010-101341","volume":"23","author":"DL Miller","year":"2011","unstructured":"Miller DL et al (2011) High-affinity rabbit monoclonal antibodies specific for amyloid peptides amyloid-beta40 and amyloid-beta42. J Alzheimers Dis 23(2):293\u2013305","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"1356_CR34","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.3233\/JAD-170898","volume":"62","author":"PD Mehta","year":"2018","unstructured":"Mehta PD et al (2018) Generation and partial characterization of rabbit monoclonal antibody to pyroglutamate amyloid-beta3-42 (pE3-Abeta). J Alzheimers Dis 62(4):1635\u20131649","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1356_CR35","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13195-018-0384-9","volume":"10","author":"K Herline","year":"2018","unstructured":"Herline K et al (2018) Immunotherapy to improve cognition and reduce pathological species in an Alzheimer\u2019s disease mouse model. Alzheimers Res Ther 10(1):54","journal-title":"Alzheimers Res Ther"},{"key":"1356_CR36","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/978-1-4939-7558-7_18","volume":"1723","author":"E Drummond","year":"2018","unstructured":"Drummond E et al (2018) Isolation of amyloid plaques and neurofibrillary tangles from archived Alzheimer\u2019s disease tissue using laser-capture microdissection for downstream proteomics. Methods Mol Biol 1723:319\u2013334","journal-title":"Methods Mol Biol"},{"key":"1356_CR37","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/978-1-4939-7558-7_18","volume":"1723","author":"E Drummond","year":"2017","unstructured":"Drummond E et al (2017) Isolation of amyloid plaques and neurofibrillary tangles from archived Alzheimer\u2019s disease tissue using laser capture microdissection for downstream proteomics. Methods Mol Biol 1723:319\u2013334","journal-title":"Methods Mol Biol"},{"issue":"9","key":"1356_CR38","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1074\/mcp.M113.031591","volume":"13","author":"J Cox","year":"2014","unstructured":"Cox J et al (2014) Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol Cell Proteomics 13(9):2513\u20132526","journal-title":"Mol Cell Proteomics"},{"issue":"4","key":"1356_CR39","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1021\/pr101065j","volume":"10","author":"J Cox","year":"2011","unstructured":"Cox J et al (2011) Andromeda: a peptide search engine integrated into the MaxQuant environment. J Proteome Res 10(4):1794\u20131805","journal-title":"J Proteome Res"},{"issue":"9","key":"1356_CR40","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","volume":"13","author":"S Tyanova","year":"2016","unstructured":"Tyanova S et al (2016) The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods 13(9):731\u2013740","journal-title":"Nat Methods"},{"issue":"1","key":"1356_CR41","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.cels.2016.11.006","volume":"4","author":"NT Seyfried","year":"2017","unstructured":"Seyfried NT et al (2017) A multi-network approach identifies protein-specific co-expression in asymptomatic and symptomatic Alzheimer\u2019s disease. Cell Syst 4(1):60\u201372","journal-title":"Cell Syst"},{"key":"1356_CR42","volume-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2020","unstructured":"R Core Team (2020) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna"},{"issue":"D1","key":"1356_CR43","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2020","unstructured":"Szklarczyk D et al (2020) The STRING database in 2021: customizable protein\u2013protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucl Acids Res 49(D1):D605\u2013D612","journal-title":"Nucl Acids Res"},{"key":"1356_CR44","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jalz.2018.10.006","volume":"15","author":"F Xiong","year":"2019","unstructured":"Xiong F, Ge W, Ma C (2019) Quantitative proteomics reveals distinct composition of amyloid plaques in Alzheimer\u2019s disease. Alzheimers Dement 15:429\u2013440","journal-title":"Alzheimers Dement"},{"issue":"35","key":"1356_CR45","doi-asserted-by":"publisher","first-page":"37061","DOI":"10.1074\/jbc.M403672200","volume":"279","author":"L Liao","year":"2004","unstructured":"Liao L et al (2004) Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection. J Biol Chem 279(35):37061\u201337068","journal-title":"J Biol Chem"},{"issue":"4","key":"1356_CR46","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1021\/pr401202d","volume":"13","author":"S Musunuri","year":"2014","unstructured":"Musunuri S et al (2014) Quantification of the brain proteome in Alzheimer\u2019s disease using multiplexed mass spectrometry. J Proteome Res 13(4):2056\u20132068","journal-title":"J Proteome Res"},{"issue":"6","key":"1356_CR47","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1021\/pr3001546","volume":"11","author":"VP Andreev","year":"2012","unstructured":"Andreev VP et al (2012) Label-free quantitative LC-MS proteomics of Alzheimer\u2019s disease and normally aged human brains. J Proteome Res 11(6):3053\u20133067","journal-title":"J Proteome Res"},{"issue":"3\u20134","key":"1356_CR48","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/prca.201100068","volume":"6","author":"LE Donovan","year":"2012","unstructured":"Donovan LE et al (2012) Analysis of a membrane-enriched proteome from postmortem human brain tissue in Alzheimer\u2019s disease. Proteomics Clin Appl 6(3\u20134):201\u2013211","journal-title":"Proteomics Clin Appl"},{"key":"1356_CR49","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1038\/emm.2013.76","volume":"45","author":"A Manavalan","year":"2013","unstructured":"Manavalan A et al (2013) Brain site-specific proteome changes in aging-related dementia. Exp Mol Med 45:e39","journal-title":"Exp Mol Med"},{"issue":"6","key":"1356_CR50","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jalz.2015.11.002","volume":"12","author":"DC Hondius","year":"2016","unstructured":"Hondius DC et al (2016) Profiling the human hippocampal proteome at all pathologic stages of Alzheimer\u2019s disease. Alzheimers Dement 12(6):654\u2013668","journal-title":"Alzheimers Dement"},{"key":"1356_CR51","doi-asserted-by":"publisher","first-page":"11138","DOI":"10.1038\/srep11138","volume":"5","author":"J Ho Kim","year":"2015","unstructured":"Ho Kim J et al (2015) Proteome-wide characterization of signalling interactions in the hippocampal CA4\/DG subfield of patients with Alzheimer\u2019s disease. Sci Rep 5:11138","journal-title":"Sci Rep"},{"issue":"7","key":"1356_CR52","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1074\/mcp.M115.056580","volume":"15","author":"RA Sweet","year":"2016","unstructured":"Sweet RA et al (2016) Apolipoprotein E*4 (APOE*4) genotype is associated with altered levels of glutamate signaling proteins and synaptic coexpression networks in the prefrontal cortex in mild to moderate Alzheimer disease. Mol Cell Proteomics 15(7):2252\u20132262","journal-title":"Mol Cell Proteomics"},{"issue":"23","key":"1356_CR53","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1002\/pmic.201600057","volume":"16","author":"CM Hales","year":"2016","unstructured":"Hales CM et al (2016) Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer\u2019s disease progression. Proteomics 16(23):3042\u20133053","journal-title":"Proteomics"},{"issue":"1","key":"1356_CR54","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13024-018-0282-4","volume":"13","author":"ECB Johnson","year":"2018","unstructured":"Johnson ECB et al (2018) Deep proteomic network analysis of Alzheimer\u2019s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease. Mol Neurodegener 13(1):52","journal-title":"Mol Neurodegener"},{"issue":"1","key":"1356_CR55","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40478-018-0524-2","volume":"6","author":"Q Zhang","year":"2018","unstructured":"Zhang Q et al (2018) Integrated proteomics and network analysis identifies protein hubs and network alterations in Alzheimer\u2019s disease. Acta Neuropathol Commun 6(1):19","journal-title":"Acta Neuropathol Commun"},{"key":"1356_CR56","doi-asserted-by":"publisher","first-page":"104509","DOI":"10.1016\/j.nbd.2019.104509","volume":"130","author":"CF Mendonca","year":"2019","unstructured":"Mendonca CF et al (2019) Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer\u2019s disease. Neurobiol Dis 130:104509","journal-title":"Neurobiol Dis"},{"key":"1356_CR57","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s42003-018-0254-9","volume":"2","author":"J Xu","year":"2019","unstructured":"Xu J et al (2019) Regional protein expression in human Alzheimer\u2019s brain correlates with disease severity. Commun Biol 2:43","journal-title":"Commun Biol"},{"key":"1356_CR58","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/alz.12089","volume":"16","author":"S Muraoka","year":"2020","unstructured":"Muraoka S et al (2020) Proteomic and biological profiling of extracellular vesicles from Alzheimer\u2019s disease human brain tissues. Alzheimers Dement 16:896\u2013907","journal-title":"Alzheimers Dement"},{"issue":"5","key":"1356_CR59","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","volume":"26","author":"ECB Johnson","year":"2020","unstructured":"Johnson ECB et al (2020) Large-scale proteomic analysis of Alzheimer\u2019s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat Med 26(5):769\u2013780","journal-title":"Nat Med"},{"key":"1356_CR60","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.neuron.2019.12.015","volume":"105","author":"B Bai","year":"2020","unstructured":"Bai B et al (2020) Deep multilayer brain proteomics identifies molecular networks in Alzheimer\u2019s disease progression. Neuron 105:975\u2013991","journal-title":"Neuron"},{"issue":"1","key":"1356_CR61","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1074\/mcp.RA119.001737","volume":"19","author":"H Haytural","year":"2020","unstructured":"Haytural H et al (2020) The proteome of the dentate terminal zone of the perforant path indicates presynaptic impairment in Alzheimer disease. Mol Cell Proteomics 19(1):128\u2013141","journal-title":"Mol Cell Proteomics"},{"issue":"43","key":"1356_CR62","doi-asserted-by":"publisher","first-page":"eaaz9360","DOI":"10.1126\/sciadv.aaz9360","volume":"6","author":"L Higginbotham","year":"2020","unstructured":"Higginbotham L et al (2020) Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer\u2019s disease. Sci Adv 6(43):eaaz9360","journal-title":"Sci Adv"},{"key":"1356_CR63","doi-asserted-by":"publisher","first-page":"105129","DOI":"10.1016\/j.nbd.2020.105129","volume":"146","author":"KE Stepler","year":"2020","unstructured":"Stepler KE et al (2020) Inclusion of African American\/Black adults in a pilot brain proteomics study of Alzheimer\u2019s disease. Neurobiol Dis 146:105129","journal-title":"Neurobiol Dis"},{"issue":"1","key":"1356_CR64","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41597-020-00650-8","volume":"7","author":"L Ping","year":"2020","unstructured":"Ping L et al (2020) Global quantitative analysis of the human brain proteome and phosphoproteome in Alzheimer\u2019s disease. Sci Data 7(1):315","journal-title":"Sci Data"},{"key":"1356_CR65","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1111\/jnc.15116","volume":"156","author":"G Sathe","year":"2020","unstructured":"Sathe G et al (2020) Quantitative proteomic analysis of the frontal cortex in Alzheimer\u2019s disease. J Neurochem 156:988","journal-title":"J Neurochem"},{"issue":"10","key":"1356_CR66","doi-asserted-by":"publisher","first-page":"7162","DOI":"10.1021\/acs.analchem.0c00655","volume":"92","author":"Z Wang","year":"2020","unstructured":"Wang Z et al (2020) 27-plex tandem mass tag mass spectrometry for profiling brain proteome in Alzheimer\u2019s disease. Anal Chem 92(10):7162\u20137170","journal-title":"Anal Chem"},{"key":"1356_CR67","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/alz.12345","volume":"17","author":"X Li","year":"2021","unstructured":"Li X et al (2021) Sequence of proteome profiles in preclinical and symptomatic Alzheimer\u2019s disease. Alzheimers Dement 17:946\u2013958","journal-title":"Alzheimers Dement"},{"key":"1356_CR68","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00401-020-02261-4","volume":"141","author":"DC Hondius","year":"2021","unstructured":"Hondius DC et al (2021) The proteome of granulovacuolar degeneration and neurofibrillary tangles in Alzheimer\u2019s disease. Acta Neuropathol 141:341\u2013358","journal-title":"Acta Neuropathol"},{"issue":"6","key":"1356_CR69","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41593-020-0635-5","volume":"23","author":"AP Wingo","year":"2020","unstructured":"Wingo AP et al (2020) Shared proteomic effects of cerebral atherosclerosis and Alzheimer\u2019s disease on the human brain. Nat Neurosci 23(6):696\u2013700","journal-title":"Nat Neurosci"},{"issue":"3","key":"1356_CR70","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1021\/acs.jproteome.9b00004","volume":"18","author":"J McKetney","year":"2019","unstructured":"McKetney J et al (2019) Proteomic atlas of the human brain in Alzheimer\u2019s disease. J Proteome Res 18(3):1380\u20131391","journal-title":"J Proteome Res"},{"issue":"1","key":"1356_CR71","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s12883-020-01849-3","volume":"20","author":"A Pearson","year":"2020","unstructured":"Pearson A et al (2020) Molecular abnormalities in autopsied brain tissue from the inferior horn of the lateral ventricles of nonagenarians and Alzheimer disease patients. BMC Neurol 20(1):317","journal-title":"BMC Neurol"},{"key":"1356_CR72","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3389\/fnmol.2018.00454","volume":"11","author":"J Dai","year":"2018","unstructured":"Dai J et al (2018) Effects of APOE genotype on brain proteomic network and cell type changes in Alzheimer\u2019s disease. Front Mol Neurosci 11:454","journal-title":"Front Mol Neurosci"},{"key":"1356_CR73","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.neurobiolaging.2021.04.012","volume":"105","author":"BC Carlyle","year":"2021","unstructured":"Carlyle BC et al (2021) Synaptic proteins associated with cognitive performance and neuropathology in older humans revealed by multiplexed fractionated proteomics. Neurobiol Aging 105:99\u2013114","journal-title":"Neurobiol Aging"},{"issue":"7","key":"1356_CR74","first-page":"1524","volume":"21","author":"T Hashimoto","year":"2002","unstructured":"Hashimoto T et al (2002) CLAC: a novel Alzheimer amyloid plaque component derived from a transmembrane precursor. CLAC-P\/collagen type XXV EMBO J 21(7):1524\u20131534","journal-title":"CLAC-P\/collagen type XXV EMBO J"},{"issue":"1","key":"1356_CR75","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10048-009-0201-5","volume":"11","author":"Y Tong","year":"2010","unstructured":"Tong Y et al (2010) COL25A1 triggers and promotes Alzheimer\u2019s disease-like pathology in vivo. Neurogenetics 11(1):41\u201352","journal-title":"Neurogenetics"},{"issue":"1","key":"1356_CR76","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3233\/JAD-151046","volume":"52","author":"PR Spilman","year":"2016","unstructured":"Spilman PR et al (2016) Netrin-1 interrupts amyloid-beta amplification, increases sAbetaPPalpha in vitro and in vivo, and improves cognition in a mouse model of Alzheimer\u2019s disease. J Alzheimers Dis 52(1):223\u2013242","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1356_CR77","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1006\/bbrc.1993.1406","volume":"192","author":"O Yasuhara","year":"1993","unstructured":"Yasuhara O et al (1993) Midkine, a novel neurotrophic factor, is present in senile plaques of Alzheimer disease. Biochem Biophys Res Commun 192(1):246\u2013251","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1356_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1755-7682-4-1","volume":"4","author":"H Muramatsu","year":"2011","unstructured":"Muramatsu H et al (2011) Midkine as a factor to counteract the deposition of amyloid beta-peptide plaques: in vitro analysis and examination in knockout mice. Int Arch Med 4(1):1","journal-title":"Int Arch Med"},{"issue":"1","key":"1356_CR79","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40478-018-0540-2","volume":"6","author":"DC Hondius","year":"2018","unstructured":"Hondius DC et al (2018) Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer\u2019s disease. Acta Neuropathol Commun 6(1):46","journal-title":"Acta Neuropathol Commun"},{"issue":"17","key":"1356_CR80","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.1073\/pnas.0501823102","volume":"102","author":"S Grau","year":"2005","unstructured":"Grau S et al (2005) Implications of the serine protease HtrA1 in amyloid precursor protein processing. Proc Natl Acad Sci U S A 102(17):6021\u20136026","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1356_CR81","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0006-8993(91)91092-F","volume":"541","author":"Y Namba","year":"1991","unstructured":"Namba Y et al (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer\u2019s disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 541(1):163\u2013166","journal-title":"Brain Res"},{"issue":"3","key":"1356_CR82","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/ng1197-263","volume":"17","author":"KR Bales","year":"1997","unstructured":"Bales KR et al (1997) Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat Genet 17(3):263\u2013264","journal-title":"Nat Genet"},{"issue":"6","key":"1356_CR83","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1073\/pnas.050004797","volume":"97","author":"DM Holtzman","year":"2000","unstructured":"Holtzman DM et al (2000) Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 97(6):2892\u20132897","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1356_CR84","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s40478-018-0612-3","volume":"6","author":"M Huttenrauch","year":"2018","unstructured":"Huttenrauch M et al (2018) Glycoprotein NMB: a novel Alzheimer\u2019s disease associated marker expressed in a subset of activated microglia. Acta Neuropathol Commun 6(1):108","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"1356_CR85","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/BF02890185","volume":"47","author":"P Eikelenboom","year":"1984","unstructured":"Eikelenboom P, Stam FC (1984) An immunohistochemical study on cerebral vascular and senile plaque amyloid in Alzheimer\u2019s dementia. Virchows Arch B Cell Pathol Incl Mol Pathol 47(1):17\u201325","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"issue":"6","key":"1356_CR86","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/s004010100414","volume":"102","author":"J van Horssen","year":"2001","unstructured":"van Horssen J et al (2001) Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer\u2019s disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains. Acta Neuropathol 102(6):604\u2013614","journal-title":"Acta Neuropathol"},{"issue":"9","key":"1356_CR87","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1096\/fj.03-1040fje","volume":"18","author":"N Watanabe","year":"2004","unstructured":"Watanabe N et al (2004) Glypican-1 as an Abeta binding HSPG in the human brain: its localization in DIG domains and possible roles in the pathogenesis of Alzheimer\u2019s disease. FASEB J 18(9):1013\u20131015","journal-title":"FASEB J"},{"issue":"6","key":"1356_CR88","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0197-4580(01)00288-3","volume":"22","author":"EG McGeer","year":"2001","unstructured":"McGeer EG et al (2001) The pentraxins: possible role in Alzheimer\u2019s disease and other innate inflammatory diseases. Neurobiol Aging 22(6):843\u2013848","journal-title":"Neurobiol Aging"},{"issue":"10","key":"1356_CR89","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.1073\/pnas.92.10.4299","volume":"92","author":"GA Tennent","year":"1995","unstructured":"Tennent GA, Lovat LB, Pepys MB (1995) Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis. Proc Natl Acad Sci U S A 92(10):4299\u20134303","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1356_CR90","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1471-4159.2006.03801.x","volume":"98","author":"DA Siegel","year":"2006","unstructured":"Siegel DA et al (2006) Tomoregulin-2 is found extensively in plaques in Alzheimer\u2019s disease brain. J Neurochem 98(1):34\u201344","journal-title":"J Neurochem"},{"issue":"3","key":"1356_CR91","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3233\/JAD-150318","volume":"48","author":"HS Hong","year":"2015","unstructured":"Hong HS et al (2015) Tomoregulin (TMEFF2) binds Alzheimer\u2019s disease amyloid-beta (Abeta) oligomer and AbetaPP and protects neurons from abeta-induced toxicity. J Alzheimers Dis 48(3):731\u2013743","journal-title":"J Alzheimers Dis"},{"issue":"2\u20133","key":"1356_CR92","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00685397","volume":"57","author":"P Eikelenboom","year":"1982","unstructured":"Eikelenboom P, Stam FC (1982) Immunoglobulins and complement factors in senile plaques: an immunoperoxidase study. Acta Neuropathol 57(2\u20133):239\u2013242","journal-title":"Acta Neuropathol"},{"issue":"29","key":"1356_CR93","doi-asserted-by":"publisher","first-page":"6457","DOI":"10.1523\/JNEUROSCI.0901-04.2004","volume":"24","author":"MI Fonseca","year":"2004","unstructured":"Fonseca MI et al (2004) Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer\u2019s disease. J Neurosci 24(29):6457\u20136465","journal-title":"J Neurosci"},{"issue":"6286","key":"1356_CR94","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S et al (2016) Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352(6286):712\u2013716","journal-title":"Science"},{"issue":"3","key":"1356_CR95","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/BF00296787","volume":"83","author":"NH Choi-Miura","year":"1992","unstructured":"Choi-Miura NH et al (1992) SP-40,40 is a constituent of Alzheimer\u2019s amyloid. Acta Neuropathol 83(3):260\u2013264","journal-title":"Acta Neuropathol"},{"issue":"2","key":"1356_CR96","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/bpa.12660","volume":"29","author":"SB Oh","year":"2019","unstructured":"Oh SB et al (2019) Clusterin contributes to early stage of Alzheimer\u2019s disease pathogenesis. Brain Pathol 29(2):217\u2013231","journal-title":"Brain Pathol"},{"issue":"3","key":"1356_CR97","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW (1984) Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120(3):885\u2013890","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"1356_CR98","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00401-016-1662-x","volume":"133","author":"E Drummond","year":"2017","unstructured":"Drummond E, Wisniewski T (2017) Alzheimer\u2019s disease: experimental models and reality. Acta Neuropathol 133(2):155\u2013175","journal-title":"Acta Neuropathol"},{"key":"1356_CR99","doi-asserted-by":"crossref","unstructured":"Shi Q et al (2017) Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP\/PS1 mice. Sci Transl Med 9(392)","DOI":"10.1126\/scitranslmed.aaf6295"},{"issue":"8","key":"1356_CR100","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/j.celrep.2019.07.060","volume":"28","author":"T Wu","year":"2019","unstructured":"Wu T et al (2019) Complement C3 is activated in human AD brain and is required for neurodegeneration in mouse models of amyloidosis and tauopathy. Cell Rep 28(8):2111\u20132123","journal-title":"Cell Rep"},{"issue":"15","key":"1356_CR101","doi-asserted-by":"publisher","first-page":"6412","DOI":"10.1073\/pnas.0701585104","volume":"104","author":"T Kanekiyo","year":"2007","unstructured":"Kanekiyo T et al (2007) Lipocalin-type prostaglandin D synthase\/beta-trace is a major amyloid beta-chaperone in human cerebrospinal fluid. Proc Natl Acad Sci U S A 104(15):6412\u20136417","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1356_CR102","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13024-020-00377-5","volume":"15","author":"S Rayaprolu","year":"2020","unstructured":"Rayaprolu S et al (2020) Flow-cytometric microglial sorting coupled with quantitative proteomics identifies moesin as a highly-abundant microglial protein with relevance to Alzheimer\u2019s disease. Mol Neurodegener 15(1):28","journal-title":"Mol Neurodegener"},{"issue":"41","key":"1356_CR103","doi-asserted-by":"publisher","first-page":"34583","DOI":"10.1074\/jbc.M112.400010","volume":"287","author":"A Darmellah","year":"2012","unstructured":"Darmellah A et al (2012) Ezrin\/radixin\/moesin are required for the purinergic P2X7 receptor (P2X7R)-dependent processing of the amyloid precursor protein. J Biol Chem 287(41):34583\u201334595","journal-title":"J Biol Chem"},{"issue":"5","key":"1356_CR104","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/ana.410260507","volume":"26","author":"DE Rosenblatt","year":"1989","unstructured":"Rosenblatt DE, Geula C, Mesulam MM (1989) Protease nexin I immunostaining in Alzheimer\u2019s disease. Ann Neurol 26(5):628\u2013634","journal-title":"Ann Neurol"},{"issue":"25","key":"1356_CR105","doi-asserted-by":"publisher","first-page":"8754","DOI":"10.1073\/pnas.0710823105","volume":"105","author":"JS Jacobsen","year":"2008","unstructured":"Jacobsen JS et al (2008) Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascade. Proc Natl Acad Sci U S A 105(25):8754\u20138759","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1356_CR106","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.neurobiolaging.2009.06.003","volume":"32","author":"RM Liu","year":"2011","unstructured":"Liu RM et al (2011) Knockout of plasminogen activator inhibitor 1 gene reduces amyloid beta peptide burden in a mouse model of Alzheimer\u2019s disease. Neurobiol Aging 32(6):1079\u20131089","journal-title":"Neurobiol Aging"},{"issue":"6","key":"1356_CR107","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1111\/jnc.13216","volume":"134","author":"KA Bruggink","year":"2015","unstructured":"Bruggink KA et al (2015) Dickkopf-related protein 3 is a potential Abeta-associated protein in Alzheimer\u2019s disease. J Neurochem 134(6):1152\u20131162","journal-title":"J Neurochem"},{"issue":"2","key":"1356_CR108","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3233\/JAD-161254","volume":"60","author":"L Zhang","year":"2017","unstructured":"Zhang L et al (2017) Dickkopf 3 (Dkk3) Improves amyloid-beta pathology, cognitive dysfunction, and cerebral glucose metabolism in a transgenic mouse model of Alzheimer\u2019s disease. J Alzheimers Dis 60(2):733\u2013746","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"1356_CR109","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13195-014-0070-5","volume":"6","author":"J Satoh","year":"2014","unstructured":"Satoh J et al (2014) PLD3 is accumulated on neuritic plaques in Alzheimer\u2019s disease brains. Alzheimers Res Ther 6(9):70","journal-title":"Alzheimers Res Ther"},{"issue":"14","key":"1356_CR110","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1007\/s00018-018-2752-9","volume":"75","author":"AS Mukadam","year":"2018","unstructured":"Mukadam AS, Breusegem SY, Seaman MNJ (2018) Analysis of novel endosome-to-Golgi retrieval genes reveals a role for PLD3 in regulating endosomal protein sorting and amyloid precursor protein processing. Cell Mol Life Sci 75(14):2613\u20132625","journal-title":"Cell Mol Life Sci"},{"key":"1356_CR111","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.nbd.2019.05.015","volume":"129","author":"AV Demirev","year":"2019","unstructured":"Demirev AV et al (2019) V232M substitution restricts a distinct O-glycosylation of PLD3 and its neuroprotective function. Neurobiol Dis 129:182\u2013194","journal-title":"Neurobiol Dis"},{"issue":"11","key":"1356_CR112","doi-asserted-by":"publisher","first-page":"6468","DOI":"10.1073\/pnas.96.11.6468","volume":"96","author":"JE Donahue","year":"1999","unstructured":"Donahue JE et al (1999) Agrin in Alzheimer\u2019s disease: altered solubility and abnormal distribution within microvasculature and brain parenchyma. Proc Natl Acad Sci U S A 96(11):6468\u20136472","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"1356_CR113","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1097\/NEN.0b013e31823b0b12","volume":"70","author":"SM Rauch","year":"2011","unstructured":"Rauch SM et al (2011) Changes in brain beta-amyloid deposition and aquaporin 4 levels in response to altered agrin expression in mice. J Neuropathol Exp Neurol 70(12):1124\u20131137","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"1356_CR114","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/ana.410370212","volume":"37","author":"GW Rebeck","year":"1995","unstructured":"Rebeck GW et al (1995) Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor\/low-density-lipoprotein receptor-related protein. Ann Neurol 37(2):211\u2013217","journal-title":"Ann Neurol"},{"issue":"7","key":"1356_CR115","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1194\/jlr.R075796","volume":"58","author":"M Shinohara","year":"2017","unstructured":"Shinohara M et al (2017) Role of LRP1 in the pathogenesis of Alzheimer\u2019s disease: evidence from clinical and preclinical studies. J Lipid Res 58(7):1267\u20131281","journal-title":"J Lipid Res"},{"issue":"2","key":"1356_CR116","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/BF00311389","volume":"84","author":"T Yamada","year":"1992","unstructured":"Yamada T et al (1992) Vimentin immunoreactivity in normal and pathological human brain tissue. Acta Neuropathol 84(2):157\u2013162","journal-title":"Acta Neuropathol"},{"issue":"6","key":"1356_CR117","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/glia.22800","volume":"63","author":"W Kamphuis","year":"2015","unstructured":"Kamphuis W et al (2015) GFAP and vimentin deficiency alters gene expression in astrocytes and microglia in wild-type mice and changes the transcriptional response of reactive glia in mouse model for Alzheimer\u2019s disease. Glia 63(6):1036\u20131056","journal-title":"Glia"},{"issue":"3","key":"1356_CR118","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1750-3639.2012.00644.x","volume":"23","author":"V Pla","year":"2013","unstructured":"Pla V et al (2013) Secretory sorting receptors carboxypeptidase E and secretogranin III in amyloid beta-associated neural degeneration in Alzheimer\u2019s disease. Brain Pathol 23(3):274\u2013284","journal-title":"Brain Pathol"},{"issue":"6","key":"1356_CR119","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1093\/cercor\/bhx046","volume":"27","author":"DM Cummings","year":"2017","unstructured":"Cummings DM et al (2017) Neuronal and peripheral pentraxins modify glutamate release and may interact in blood-brain barrier failure. Cereb Cortex 27(6):3437\u20133448","journal-title":"Cereb Cortex"},{"issue":"49","key":"1356_CR120","doi-asserted-by":"publisher","first-page":"12735","DOI":"10.1523\/JNEUROSCI.0575-06.2006","volume":"26","author":"MA Abad","year":"2006","unstructured":"Abad MA et al (2006) Neuronal pentraxin 1 contributes to the neuronal damage evoked by amyloid-beta and is overexpressed in dystrophic neurites in Alzheimer\u2019s brain. J Neurosci 26(49):12735\u201312747","journal-title":"J Neurosci"},{"key":"1356_CR121","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.neuroscience.2012.07.038","volume":"223","author":"DM Hafez","year":"2012","unstructured":"Hafez DM et al (2012) F-spondin gene transfer improves memory performance and reduces amyloid-beta levels in mice. Neuroscience 223:465\u2013472","journal-title":"Neuroscience"},{"issue":"5","key":"1356_CR122","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3390\/cells9051275","volume":"9","author":"SY Park","year":"2020","unstructured":"Park SY et al (2020) SPON1 can reduce amyloid beta and reverse cognitive impairment and memory dysfunction in Alzheimer\u2019s disease mouse model. Cells 9(5):1275","journal-title":"Cells"},{"issue":"28","key":"1356_CR123","doi-asserted-by":"publisher","first-page":"9650","DOI":"10.1074\/jbc.RA119.012386","volume":"295","author":"N Gotoh","year":"2020","unstructured":"Gotoh N et al (2020) Amyloidogenic processing of amyloid beta protein precursor (APP) is enhanced in the brains of alcadein alpha-deficient mice. J Biol Chem 295(28):9650\u20139662","journal-title":"J Biol Chem"},{"issue":"24","key":"1356_CR124","first-page":"4176","volume":"27","author":"EF Griffin","year":"2018","unstructured":"Griffin EF et al (2018) Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer\u2019s and Parkinson\u2019s disease models of neurodegeneration. Hum Mol Genet 27(24):4176\u20134193","journal-title":"Hum Mol Genet"},{"issue":"17","key":"1356_CR125","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1111\/febs.13353","volume":"282","author":"Y Teranishi","year":"2015","unstructured":"Teranishi Y et al (2015) Proton myo-inositol cotransporter is a novel gamma-secretase associated protein that regulates Abeta production without affecting Notch cleavage. FEBS J 282(17):3438\u20133451","journal-title":"FEBS J"},{"issue":"23","key":"1356_CR126","doi-asserted-by":"publisher","first-page":"5322","DOI":"10.1523\/JNEUROSCI.1170-04.2004","volume":"24","author":"G Novarino","year":"2004","unstructured":"Novarino G et al (2004) Involvement of the intracellular ion channel CLIC1 in microglia-mediated beta-amyloid-induced neurotoxicity. J Neurosci 24(23):5322\u20135330","journal-title":"J Neurosci"},{"issue":"7","key":"1356_CR127","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1073\/pnas.1719808115","volume":"115","author":"S Sole-Domenech","year":"2018","unstructured":"Sole-Domenech S et al (2018) Lysosomal enzyme tripeptidyl peptidase 1 destabilizes fibrillar Abeta by multiple endoproteolytic cleavages within the beta-sheet domain. Proc Natl Acad Sci U S A 115(7):1493\u20131498","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1356_CR128","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13024-020-00384-6","volume":"15","author":"H Wang","year":"2020","unstructured":"Wang H et al (2020) Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer\u2019s disease. Mol Neurodegener 15(1):43","journal-title":"Mol Neurodegener"},{"key":"1356_CR129","doi-asserted-by":"crossref","unstructured":"Chen G et al (2021) Netrin-1 receptor UNC5C cleavage by active delta-secretase enhances neurodegeneration, promoting Alzheimer's disease pathologies. Sci Adv 7(16)","DOI":"10.1126\/sciadv.abe4499"},{"key":"1356_CR130","unstructured":"Allen Institute for Brain Science (2019) Allen cell types database-multiple cortical areas smart-seq. https:\/\/celltypes.brain-map.org\/rnaseq\/human_ctx_smart-seq"},{"issue":"559","key":"1356_CR131","doi-asserted-by":"publisher","first-page":"eaaz8048","DOI":"10.1126\/scitranslmed.aaz8048","volume":"12","author":"MK Montgomery","year":"2020","unstructured":"Montgomery MK et al (2020) SMOC1 is a glucose-responsive hepatokine and therapeutic target for glycemic control. Sci Transl Med 12(559):eaaz8048","journal-title":"Sci Transl Med"},{"issue":"2","key":"1356_CR132","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/cvr\/cvv098","volume":"106","author":"K Awwad","year":"2015","unstructured":"Awwad K et al (2015) Role of secreted modular calcium-binding protein 1 (SMOC1) in transforming growth factor beta signalling and angiogenesis. Cardiovasc Res 106(2):284\u2013294","journal-title":"Cardiovasc Res"},{"issue":"1","key":"1356_CR133","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ajhg.2010.11.012","volume":"88","author":"I Okada","year":"2011","unstructured":"Okada I et al (2011) SMOC1 is essential for ocular and limb development in humans and mice. Am J Hum Genet 88(1):30\u201341","journal-title":"Am J Hum Genet"},{"issue":"Pt 3","key":"1356_CR134","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/brain\/awt362","volume":"137","author":"A Rijal Upadhaya","year":"2014","unstructured":"Rijal Upadhaya A et al (2014) Biochemical stages of amyloid-beta peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer\u2019s disease. Brain 137(Pt 3):887\u2013903","journal-title":"Brain"},{"issue":"1","key":"1356_CR135","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0002-9440(10)64700-1","volume":"156","author":"GK Gouras","year":"2000","unstructured":"Gouras GK et al (2000) Intraneuronal Abeta42 accumulation in human brain. Am J Pathol 156(1):15\u201320","journal-title":"Am J Pathol"},{"issue":"5","key":"1356_CR136","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1016\/S0002-9440(10)64463-X","volume":"161","author":"RH Takahashi","year":"2002","unstructured":"Takahashi RH et al (2002) Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol 161(5):1869\u20131879","journal-title":"Am J Pathol"},{"issue":"5","key":"1356_CR137","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00401-010-0679-9","volume":"119","author":"GK Gouras","year":"2010","unstructured":"Gouras GK et al (2010) Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer\u2019s disease. Acta Neuropathol 119(5):523\u2013541","journal-title":"Acta Neuropathol"},{"issue":"2\u20133","key":"1356_CR138","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000354776","volume":"13","author":"GK Gouras","year":"2014","unstructured":"Gouras GK, Willen K, Faideau M (2014) The inside-out amyloid hypothesis and synapse pathology in Alzheimer\u2019s disease. Neurodegener Dis 13(2\u20133):142\u2013146","journal-title":"Neurodegener Dis"},{"issue":"2","key":"1356_CR139","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1046\/j.1365-2559.2001.01082.x","volume":"38","author":"MR D'Andrea","year":"2001","unstructured":"D\u2019Andrea MR et al (2001) Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer\u2019s disease. Histopathology 38(2):120\u2013134","journal-title":"Histopathology"},{"key":"1356_CR140","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.nbd.2014.07.011","volume":"71","author":"A Pensalfini","year":"2014","unstructured":"Pensalfini A et al (2014) Intracellular amyloid and the neuronal origin of Alzheimer neuritic plaques. Neurobiol Dis 71:53\u201361","journal-title":"Neurobiol Dis"},{"issue":"1","key":"1356_CR141","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman DS et al (2021) Alzheimer disease. Nat Rev Dis Primers 7(1):33","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"1356_CR142","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.devcel.2011.10.007","volume":"21","author":"C Rosa-Ferreira","year":"2011","unstructured":"Rosa-Ferreira C, Munro S (2011) Arl8 and SKIP act together to link lysosomes to kinesin-1. Dev Cell 21(6):1171\u20131178","journal-title":"Dev Cell"},{"issue":"14","key":"1356_CR143","doi-asserted-by":"publisher","first-page":"E2955","DOI":"10.1073\/pnas.1616363114","volume":"114","author":"GG Farias","year":"2017","unstructured":"Farias GG et al (2017) BORC\/kinesin-1 ensemble drives polarized transport of lysosomes into the axon. Proc Natl Acad Sci U S A 114(14):E2955\u2013E2964","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"1356_CR144","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.devcel.2021.03.032","volume":"56","author":"JC Roney","year":"2021","unstructured":"Roney JC et al (2021) Lipid-mediated motor-adaptor sequestration impairs axonal lysosome delivery leading to autophagic stress and dystrophy in Niemann-Pick type C. Dev Cell 56(10):1452\u20131468","journal-title":"Dev Cell"},{"issue":"1\u20132","key":"1356_CR145","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/0006-8993(94)91858-9","volume":"640","author":"AM Cataldo","year":"1994","unstructured":"Cataldo AM, Hamilton DJ, Nixon RA (1994) Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease. Brain Res 640(1\u20132):68\u201380","journal-title":"Brain Res"},{"issue":"2","key":"1356_CR146","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0006-8993(90)90456-L","volume":"513","author":"AM Cataldo","year":"1990","unstructured":"Cataldo AM et al (1990) Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer\u2019s disease: evidence for a neuronal origin. Brain Res 513(2):181\u2013192","journal-title":"Brain Res"},{"issue":"9","key":"1356_CR147","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1111\/ejn.13913","volume":"47","author":"S Hassiotis","year":"2018","unstructured":"Hassiotis S et al (2018) Lysosomal LAMP1 immunoreactivity exists in both diffuse and neuritic amyloid plaques in the human hippocampus. Eur J Neurosci 47(9):1043\u20131053","journal-title":"Eur J Neurosci"},{"issue":"1","key":"1356_CR148","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0002-9440(10)63295-6","volume":"165","author":"H Kowa","year":"2004","unstructured":"Kowa H et al (2004) Mostly separate distributions of CLAC- versus Abeta40- or thioflavin S-reactivities in senile plaques reveal two distinct subpopulations of beta-amyloid deposits. Am J Pathol 165(1):273\u2013281","journal-title":"Am J Pathol"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01356-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-022-01356-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01356-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T13:35:28Z","timestamp":1675258528000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-022-01356-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,13]]},"references-count":148,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1356"],"URL":"https:\/\/doi.org\/10.1186\/s40478-022-01356-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1316035\/v1","asserted-by":"object"}]},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,13]]},"assertion":[{"value":"31 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"53"}}